Ards Research Analysis
Across 2025-Q1, ARDS research coalesced around host-directed mechanisms, endothelial protection, and pragmatic ICU automation. Foundational January mechanistic studies (IKKβ–NLRP3 trafficking, H3K14 lactylation–ferroptosis, PRDX6–TLR4 DAMP) catalyzed a quarter-long focus on druggable host pathways. These were complemented in February by first-in-class endothelial-stabilizing molecules (p38α:MK2 modulation, PTP4A3 inhibition), reinforcing anti–vascular leak strategies. Pro-resolution and neuroimm